androst-5-en-3-ol has been researched along with phenobarbital in 1 studies
| Studies (androst-5-en-3-ol) | Trials (androst-5-en-3-ol) | Recent Studies (post-2010) (androst-5-en-3-ol) | Studies (phenobarbital) | Trials (phenobarbital) | Recent Studies (post-2010) (phenobarbital) |
|---|---|---|---|---|---|
| 12 | 0 | 2 | 18,336 | 619 | 1,117 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oguri, K; Yamada, H; Yamaguchi, T | 1 |
1 other study(ies) available for androst-5-en-3-ol and phenobarbital
| Article | Year |
|---|---|
Suppression of the expression of the CYP2B1/2 gene by retinoic acids.
Topics: Androstenols; Animals; Aryl Hydrocarbon Hydroxylases; Cells, Cultured; Constitutive Androstane Receptor; Cytochrome P-450 CYP2B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dimerization; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Induction; Hepatocytes; Immunoblotting; Isomerism; Ligands; Liver; Male; Phenobarbital; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Steroid Hydroxylases; Transcription Factors; Tretinoin | 2000 |